Warfarin Medications

Warfarin is an oral anticoagulant that inhibits vitamin K-dependent clotting factors. It is primarily used for prophylaxis and treatment of venous thromboembolism and to prevent stroke in atrial fibrillation.

Coumadin

Warfarin

$0.40 per pill

1 | 2 | 5mg

Select pack

What is Warfarin

Warfarin is a vitamin K antagonist that has been used for decades to prevent and treat thromboembolic disorders. It belongs to the class of oral anticoagulants and works by inhibiting the synthesis of clotting factors II, VII, IX, and X as well as the natural anticoagulants protein C and protein S. In Australia, warfarin is marketed under the brand name Marevan and is also available as generic warfarin tablets. Its primary clinical applications include long-term stroke prevention in atrial fibrillation, treatment of deep-vein thrombosis (DVT) and pulmonary embolism (PE), and thromboprophylaxis for patients with mechanical heart valves. Although newer direct oral anticoagulants (DOACs) have entered the market, warfarin remains a cost-effective option, especially where frequent monitoring and dose adjustments are feasible. Off-label, clinicians sometimes employ warfarin for antiphospholipid syndrome or for recurrent thrombosis when DOACs are contraindicated, but these uses are not formally approved.

What is Warfarin?

Warfarin is classified as a vitamin K antagonist oral anticoagulant (VKA). The Therapeutic Goods Administration (TGA) approved the drug for human use in 1954, initially for the prevention of postoperative clot formation. Since then, its label has expanded to include atrial fibrillation, venous thromboembolism, and mechanical prosthetic heart valves, with each indication carrying a specific target International Normalised Ratio (INR) range.

At the molecular level, warfarin blocks the enzyme vitamin K epoxide reductase complex 1 (VKORC1), which recycles vitamin K to its active hydroquinone form. Without functional vitamin K, the liver cannot gamma-carboxylate the glutamic acid residues of clotting factors II, VII, IX, and X, leading to reduced clotting ability. The drug is supplied as 1 mg, 2 mg, 2.5 mg, 3 mg, 4 mg, 5 mg, and 6 mg tablets, all of which can be ordered from our online pharmacy in both brand and generic formulations.

How Warfarin Works

Mechanism of Action

Warfarin competitively inhibits VKORC1, preventing the regeneration of reduced vitamin K. This interruption halts the post-translational modification of the vitamin K-dependent clotting factors, rendering them biologically inactive. The effect is dose-dependent and varies with individual genetic polymorphisms in VKORC1 and CYP2C9, the primary metabolic pathway for warfarin clearance.

Therapeutic Effects

By diminishing functional clotting factors, warfarin reduces the propensity for fibrin clot formation. In atrial fibrillation, this translates into a 60-70 % relative risk reduction for ischemic stroke. In patients with mechanical heart valves, warfarin maintains a therapeutic INR that prevents prosthetic-related thromb-threatening complication.

Onset and Duration

The anticoagulant effect begins within 24-48 hours, but maximal inhibition of clotting factor synthesis typically requires 4-5 days. Warfarin’s elimination half-life averages 40 hours, allowing once-daily dosing once the therapeutic INR is achieved. Because factor II (prothrombin) has the longest half-life (~60 hours), clinicians usually monitor INR daily during initiation and then adjust the dose to sustain the target range.

Approved Uses and Applications

Approved Indications

Atrial fibrillation (non-valvular) - target INR 2.-3..
Deep-vein thrombosis and pulmonary embolism - initial intensive phase followed by maintenance dosing, INR 2.-3.
Mechanical heart valve replacement - target INR 2.5-3.5 (or higher for mitral position).
Anticoagulation during certain cardiac surgeries - short-term bridging.

These indications are endorsed by the TGA and reflected in the Australian Medicines Handbook.

Off-Label Uses

Warfarin is sometimes employed for antiphospholipid antibody syndrome and for patients who cannot receive DOACs due to severe renal impairment. Such applications are supported by case series and guideline recommendations but lack formal regulatory approval.

Clinical Efficacy

Large randomized trials, such as the Warfarin-Aspirin Recurrent Stroke Study (WARSS) published in The New England Journal of Medicine, demonstrated that warfarin reduced recurrent ischemic stroke by 15 % compared with aspirin in patients with prior stroke. In the International Normalised Ratio Study, maintaining INR between 2. and 3. lowered the risk of major venous thromboembolism recurrence to 3 % per year, compared with 8 % in inadequately anticoagulated patients.

Buying Warfarin from Our Online Pharmacy

Why Choose Our Service

Accessing warfarin can be challenging in remote Australian regions where local pharmacies have limited stock. Our pharmacy service bridges that gap, delivering medication directly to your door while complying with TGA import regulations.

Brand Options

Marevan (brand) - 2 mg and 5 mg tablets.
Coumadin (international brand) - 2.5 mg and 5 mg.
Warfarin sodium (generic) - available in 1 mg - 6 mg strengths.

Ordering generic warfarin through our online pharmacy typically saves 30-45 % compared with brand-only purchases.

Quality & Safety

We partner with licensed international pharmacies that source products from manufacturers inspected under WHO Good Manufacturing Practices. Every batch is accompanied by a verified batch-release certificate.

Pricing & Access

Competitive pricing starts at AU$.25 per 1 mg tablet for generics. A Lifetime 10 % discount on all reorders is automatically applied to returning customers.

Discreet Delivery

Standard shipping arrives within three weeks, while express delivery-available for an additional fee-reaches most Australian postcodes in ~7 days. Packages are sealed in unmarked, tamper-evident envelopes to protect privacy.

Dosing, Formulations & Administration

Available Formulations

Warfarin is supplied as oral tablets in strengths ranging from 1 mg to 6 mg. No liquid or injectable forms are marketed for routine outpatient use in Australia.

Typical Dosing Ranges

Atrial fibrillation - initial dose 5 mg daily; some clinicians start with 2 mg if the patient is >70 years, has low body weight, or carries CYP2C92/3 alleles.
Deep-vein thrombosis - loading dose 10 mg daily for 2-3 days, followed by a maintenance dose of 2-5 mg to achieve target INR.
Mechanical heart valve - commonly 5-10 mg daily, titrated to INR 2.5-3.5.

These examples illustrate common clinical practice; the exact dose must be individualized by a qualified clinician who reviews the patient’s genetics, liver function, interacting drugs, and bleeding risk.

Administration Guidelines

Warfarin should be taken once daily at the same time, preferably in the evening to align peak effect with nocturnal INR testing. Food does not significantly alter absorption, but vitamin K-rich meals (e.g., leafy greens) can blunt anticoagulant effect and should be consumed consistently day-to-day. Patients should avoid abrupt changes in dietary vitamin K intake and report any new herbal supplements.

Never adjust the dose without professional guidance; a healthcare provider must determine the precise regimen based on INR trends and overall health status.

Safety Profile & Considerations

Common Side Effects

Bruising or minor bleeding - reported in >10 % of patients.
Epistaxis (nosebleeds) - occurs in ~5 % of users.
Gastrointestinal discomfort - nausea or dyspepsia in ~4 %.
Hair loss - occasional, self-limited.

These effects are generally mild and manageable with dose adjustment.

Serious Adverse Events

Major hemorrhage (intracranial or gastrointestinal) - incidence ≈1-3 % per year, necessitating immediate medical attention.
Skin necrosis - rare (<0.01 %) but life-threatening; usually appears within the first week of therapy.
Purple toe syndrome - extremely uncommon, presenting as painful, violaceous toe discoloration.

Contraindications

Active, uncontrolled bleeding.
Pregnancy (Category D) - warfarin crosses the placenta and may cause fetal hemorrhage or teratogenicity.
Severe uncontrolled hypertension (>180/110 mmHg).
Recent intracranial surgery or hemorrhagic stroke.

Drug Interactions

CYP2C9 inhibitors (e.g., amiodarone, fluconazole, metronidazole) increase warfarin plasma levels → heightened bleeding risk.
CYP inducers (e.g., rifampicin, carbamazepine) decrease effect → sub-therapeutic INR.
Antiplatelet agents (aspirin, clopidogrel)NSAIDs** amplify bleeding propensity.
Herbal supplements such as ginkgo biloba, St. John’s wort, and high-dose vitamin E may affect INR.

Patients should provide a complete medication list to their prescriber before any change.

Special Populations

Pregnancy & lactation: Warfarin is contraindicated in pregnancy; low-molecular-weight heparin is preferred. Limited data suggest minimal transfer into breast milk, but most clinicians avoid it postpartum.
Elderly: Age-related decline in hepatic metabolism and increased sensitivity raise bleeding risk; lower starting doses (2-3 mg) are common.
Renal impairment: Warfarin is largely hepatically cleared; however, severe renal failure may alter protein binding, warranting closer INR monitoring.
Hepatic disease: Reduced synthesis of clotting factors can potentiate warfarin’s effect; dose reductions and frequent INR checks are advised.

Frequently Asked Questions

How does warfarin differ from newer direct oral anticoagulants? Warfarin requires regular INR monitoring and is affected by diet and many drug interactions, whereas DOACs have fixed dosing and predictable pharmacokinetics that eliminate routine lab checks.
How long before warfarin produces noticeable effects for atrial fibrillation? Therapeutic anticoagulation usually is achieved after 4-5 days of consistent dosing, once the INR stabilises within the target range.
What should I do if I experience bruising while taking warfar? Minor bruising is common, but you should report any sudden increase in size, pain, or associated bleeding to your clinician. They may adjust the dose or review interacting substances.
Can I take ibuprofen with warfarin? Ibuprofen, an NSAID, increases gastrointestinal bleeding risk and can potentiate warfarin’s effect. Use only under medical supervision and consider acetaminophen as a safer alternative.
Does eating green vegetables affect my warfarin dose? Foods high in vitamin K (spinach, kale, broccoli) can lower INR if intake varies dramatically. Aim for a consistent amount each day and discuss any major dietary changes with your prescriber.
What is the recommended frequency for INR monitoring after dose stabilization? Once a stable INR is achieved, most guidelines advise testing every 4 weeks, but more frequent checks may be needed after medication changes, illness, or dietary shifts.
Are there genetic tests that help tailor warfarin dosing? Testing for VKORC1 and CYP2C9 polymorphisms can predict dose requirements, especially in populations with known variants. However, routine testing is not universally performed in Australia.
Is warfarin safe for patients with a history of stomach ulcers? Ulcer disease raises the risk of gastrointestinal bleeding. If you have a prior ulcer, your clinician may choose a lower target INR, co-prescribe a proton-pump inhibitor, or consider an alternative anticoagulant.
Can I travel internationally with warfarin? Yes, but keep a copy of the prescription, a letter from your doctor, and ensure you comply with Australian export rules. Pack the medication in its original container and store it at room temperature.
What information should I provide my doctor when discussing warfarin?
- Complete list of current prescription and over-the-counter medications, including supplements.
- Details of any recent surgeries, dental procedures, or bleeding episodes.
- Typical dietary habits, especially intake of leafy green vegetables.
- History of liver disease, kidney impairment, or prior thrombotic events.

Disclaimer

The information provided about warfarin is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing warfarin for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing warfarin.